If and only if

IFF Appoints Nicolas Mirzayantz President of IFF’s Nourish Division

Retrieved on: 
Wednesday, July 28, 2021

IFF (NYSE: IFF) today announced that Nicolas Mirzayantz, current President, Scent, has been appointed President of IFFs Nourish division, effective September 1, 2021.

Key Points: 
  • IFF (NYSE: IFF) today announced that Nicolas Mirzayantz, current President, Scent, has been appointed President of IFFs Nourish division, effective September 1, 2021.
  • Mr. Mirzayantz will succeed Kathy Fortmann, current President, Nourish, who has decided to pursue other opportunities outside of IFF.
  • We could not be more pleased to have Nicolas lead our Nourish division, said IFF Chairman and CEO, Andreas Fibig.
  • Nicolas is joining a Nourish division with a tremendous opportunity to build on significant sales momentum and strong customer interest in IFFs differentiated portfolio and capabilities.

IFF's Health & Biosciences Division Announces Agreement for Commercializing DSM Bio-based Products & Services Yeast Technology

Retrieved on: 
Wednesday, June 2, 2021

In addition, IFF's R&D team will collaborate with DSM scientists to accelerate IFF's on-going development of high-performance yeast products.

Key Points: 
  • In addition, IFF's R&D team will collaborate with DSM scientists to accelerate IFF's on-going development of high-performance yeast products.
  • IFF will launch eBoost GTX along with other new yeast products during 2021 including SYNERXIA RUBY and SYNERXIA SAPPHIRE.
  • Atul Thakrar, President of DSM Bio-based Products & Services stated, "We are excited by the potential of this agreement with IFF.
  • Cindy McCracken, Vice President Grain Processing Business, Health & Biosciences division, IFF stated, "We are ready to serve the needs of new and current customers of both IFF and DSM.

IFF Declares Dividend for Second Quarter 2021

Retrieved on: 
Wednesday, May 5, 2021

b'IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.77 per share of its common stock, payable on July 6, 2021 to shareholders of record as of June 25, 2021.\nAt IFF (NYSE: IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world \xe2\x80\x93 from global icons to unexpected innovations and experiences.

Key Points: 
  • b'IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.77 per share of its common stock, payable on July 6, 2021 to shareholders of record as of June 25, 2021.\nAt IFF (NYSE: IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world \xe2\x80\x93 from global icons to unexpected innovations and experiences.
  • With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves.
  • Together, we will do more good for people and planet.
  • Learn more at iff.com, Twitter , Facebook , Instagram , and LinkedIn .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210505006076/en/\n'

IFF to Complete Merger With DuPont’s Nutrition & Biosciences Business

Retrieved on: 
Monday, February 1, 2021

IFF (NYSE: IFF) to complete the previously announced merger of IFF and DuPonts Nutrition & Biosciences (N&B) business, pursuant to a Reverse Morris Trust transaction today.

Key Points: 
  • IFF (NYSE: IFF) to complete the previously announced merger of IFF and DuPonts Nutrition & Biosciences (N&B) business, pursuant to a Reverse Morris Trust transaction today.
  • Shares of the combined companys common stock will trade on the New York Stock Exchange under the symbol IFF.
  • Through an unprecedented last 12 months, both the IFF and N&B teams have remained incredibly focused on executing our respective business plans and setting the foundation to bring this combination to life.
  • Im extremely proud of what our teams have accomplished to complete the transaction on time despite a year of unprecedented challenges.

IFF Previews Financial Profile, Governance and Strategic Transformation Initiatives Effective at Completion of Combination with DuPont N&B

Retrieved on: 
Monday, January 11, 2021

IFF will be a new Company for a new era, said IFF Chairman and CEO, Andreas Fibig.

Key Points: 
  • IFF will be a new Company for a new era, said IFF Chairman and CEO, Andreas Fibig.
  • Customers across end markets expect more from their value chain partners and the new IFF is well-positioned to deliver.
  • I would also like to thank and acknowledge the four directors that will be departing our Board upon the completion of the merger.
  • Marcello, David, Katherine and Li-Huei have provided invaluable leadership and expertise as IFF has pursued our transformation and created this foundation for our next stage of growth.

IFF Declares Dividend for Fourth Quarter 2020

Retrieved on: 
Wednesday, December 9, 2020

IFF (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF), a leading innovator of scent, taste, and nutrition, announced that its Board of Directors has declared a regular quarterly cash dividend of $0.77 per share of its common stock, payable on January 7, 2021 to shareholders of record as of December 28, 2020.

Key Points: 
  • IFF (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF), a leading innovator of scent, taste, and nutrition, announced that its Board of Directors has declared a regular quarterly cash dividend of $0.77 per share of its common stock, payable on January 7, 2021 to shareholders of record as of December 28, 2020.
  • At IFF (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF), were using Uncommon Sense to create what the world needs.
  • As a collective of unconventional thinkers and creators, we put science and artistry to work to create unique and unexpected scents, tastes, experiences and ingredients for the products our world craves.
  • Learn more at iff.com, Twitter, Facebook, Instagram, and LinkedIn.

IFF Receives All Required Antitrust Clearances for Intended Combination with DuPont’s Nutrition & Biosciences Business

Retrieved on: 
Monday, December 7, 2020

IFF (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF) and DuPont (NYSE: DD) today announced that the intended combination of DuPonts Nutrition & Biosciences (N&B) business with IFF has received unconditional clearance from the European Commission.

Key Points: 
  • IFF (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF) and DuPont (NYSE: DD) today announced that the intended combination of DuPonts Nutrition & Biosciences (N&B) business with IFF has received unconditional clearance from the European Commission.
  • With receipt of this clearance, the intended combination has received all required antitrust clearances and approvals that are a condition to the closing of the transaction.
  • IFF and DuPont continue to expect to close the transaction in the first quarter of 2021.
  • At IFF (NYSE:IFF) (Euronext Paris: IFF) (TASE: IFF), were using Uncommon Sense to create what the world needs.

IFF Named to the Dow Jones Sustainability Index World and North America

Retrieved on: 
Thursday, November 19, 2020

Named to both the 2020 World Index and the North America Index, this distinction validates IFFs leadership position in sustainability performance and underscores the companys commitment to executing on key environmental, social and governance (ESG) priorities.

Key Points: 
  • Named to both the 2020 World Index and the North America Index, this distinction validates IFFs leadership position in sustainability performance and underscores the companys commitment to executing on key environmental, social and governance (ESG) priorities.
  • The SAM Corporate Sustainability Assessment (CSA) is used as the basis for evaluating and selecting companies for inclusion in the DJSI.
  • Similarly, IFF ranks among the top 20 percent of the 600 largest companies in the S&P Global Brand Market Index in North America.
  • At IFF (NYSE:IFF) (Euronext Paris: IFF) (TASE: IFF), were using Uncommon Sense to create what the world needs.

IFF Releases 12th Annual Speed Smelling™ Collectors Edition: Slow Smelling™ to Celebrate the Timelessness of Fragrance

Retrieved on: 
Thursday, October 8, 2020

With the unprecedented challenges the world has faced this year, the 2020 Slow Smelling collection was inspired by the suspension of time and of calmness as a way of reconnection to the self.

Key Points: 
  • With the unprecedented challenges the world has faced this year, the 2020 Slow Smelling collection was inspired by the suspension of time and of calmness as a way of reconnection to the self.
  • The coffrets presented at the virtual event, held in June, are now available for consumers to purchase online.
  • We are thrilled to support the artistry of our perfumers and to celebrate the mastery of the craft with this edition.
  • At IFF (NYSE:IFF) (Euronext Paris: IFF) (TASE: IFF), were using Uncommon Sense to create what the world needs.

IFF Shareholders Approve Merger with DuPont’s Nutrition & Biosciences Business

Retrieved on: 
Thursday, August 27, 2020

IFF (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF) and DuPont (NYSE: DD) announced that, during a special meeting held earlier today, IFF shareholders voted to approve the issuance of shares of IFF common stock in connection with the previously announced proposed merger of IFF and DuPonts Nutrition & Biosciences (N&B) business pursuant to a Reverse Morris Trust transaction.

Key Points: 
  • IFF (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF) and DuPont (NYSE: DD) announced that, during a special meeting held earlier today, IFF shareholders voted to approve the issuance of shares of IFF common stock in connection with the previously announced proposed merger of IFF and DuPonts Nutrition & Biosciences (N&B) business pursuant to a Reverse Morris Trust transaction.
  • IFF and DuPont continue to target closing the transaction in the first quarter of 2021, subject to regulatory approvals and closing conditions.
  • At IFF (NYSE:IFF) (Euronext Paris: IFF) (TASE: IFF), were using Uncommon Sense to create what the world needs.
  • DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries.